Kindred Biosciences, Inc. IPO Research Information

Kindred Biosciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Kindred Biosciences, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Kindred Biosciences, Inc.	KIN - NASDAQ	$6.00-$8.00	$7.00	$8.75	7.5 million	12/12/2014
Underwriter(s): Leerink Partners, BMO Capital Markets, Guggenheim Securities
Co-Manager(s):
Industry: Health Care
Filing(s):

Kindred Biosciences, Inc. Quote & Chart - Click for current quote - KIN

About Kindred Biosciences, Inc. (adapted from Kindred Biosciences, Inc. prospectus):
They are a development stage biopharmaceutical company focused on saving and improving the lives of pets.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "KIN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.